Insider Trading Activity Natera Inc. (NASDAQ:NTRA) – Insider Sold 1,087 shares of Stock

ME Staff
-
0

Insider Trading Activity For Natera Inc. (NASDAQ:NTRA)

Jonathan Sheena , Insider of Natera Inc. (NASDAQ:NTRA) reportedly Sold 1,087 shares of the company’s stock at an average price of 12 for a total transaction amount of $13,044.00 SEC Form

Insider Trading History For Natera Inc. (NASDAQ:NTRA)

  • On 7/2/2015 James Healy, Director, bought 400,000 with an average share price of $22.81 per share and the total transaction amounting to $9,124,000.00.
  • On 7/8/2015 James Healy, Director, bought 350,000 with an average share price of $18.00 per share and the total transaction amounting to $6,300,000.00.
  • On 12/29/2015 Matthew Rabinowitz, CEO, sold 83,804 with an average share price of $10.62 per share and the total transaction amounting to $889,998.48.
  • On 12/29/2015 Jonathan Sheena, CTO, sold 50,000 with an average share price of $10.44 per share and the total transaction amounting to $522,000.00.
  • On 12/31/2015 Matthew Rabinowitz, CEO, sold 111,513 with an average share price of $10.83 per share and the total transaction amounting to $1,207,685.79.
  • On 1/4/2016 Jonathan Sheena, CTO, sold 25,000 with an average share price of $10.06 per share and the total transaction amounting to $251,500.00.
  • On 1/5/2016 Matthew Rabinowitz, CEO, sold 54,683 with an average share price of $10.37 per share and the total transaction amounting to $567,062.71.

    • Analyst Ratings For Natera Inc. (NASDAQ:NTRA)
    These are 5 Buy RatingsThe current consensus rating for Natera Inc. (NASDAQ:NTRA) is Buy (Score: 3.00) with a consensus target price of $18.80 , a potential (56.28% upside)

    Analyst Ratings History For Natera Inc. (NASDAQ:NTRA)

    • On 9/28/2015 Wedbush Upgraded rating Neutral to Outperform with a price target of $20.00
    • On 3/9/2016 Robert W. Baird Lower Price Target of rating Outperform with a price target of $18.00 to $15.00
    • On 3/11/2016 Piper Jaffray Cos. Reiterated Rating Overweight with a price target of $24.00 to $22.00
    • On 6/3/2016 Cowen and Company Reiterated Rating Outperform with a price target of $17.00
    • On 8/5/2016 Morgan Stanley Set Price Target of rating Buy with a price target of $20.00
    • On 11/10/2016 Benchmark Co. Boost Price Target of rating Buy with a price target of $16.00 to $20.00

    About Natera Inc. (NASDAQ:NTRA)
    Natera, Inc. is a diagnostics company. The Company’s product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening (Horizon) to determine carrier status for various severe genetic diseases that could be passed on to the carrier’s children; Spectrum Pre-implantation Genetic Screening (PGS) and Spectrum Pre-implantation Genetic Diagnosis (PGD) to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization (IVF) cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother’s blood and a blood sample from the alleged father(s).

    Recent Trading Activity for Natera Inc. (NASDAQ:NTRA)
    Shares of Natera Inc. closed the previous trading session at 12.03 0.00 0.00% with 429,359 shares trading hands.